Kadans Science Partner has acquired Windrush Innovation Centre in Oxford with plans to demolish and rebuild it.
Kadans bought the building from Tozi Ltd. Its tenant, Oxford Biomedica, will move into the new 60,000 sq ft lab and office space development. Knight Frank advised Kadans in the deal.
James Sheppard, managing director (UK & Ireland) for Kadans, said: “We are delighted to continue to be building our portfolio in Oxford. The development at Windrush Innovation Centre will provide much needed, high specification laboratory space in the Oxford market.
“We look forward to a continued productive relationship with the tenant, Oxford Biomedica, as they build their position as a quality and innovation-led viral vector CDMO (contract, development and manufacturing organisation).”
Freddie Owen, partner at Knight Frank, said: “After successfully acquiring Oxford Biomedica’s HQ facility in 2022, this new development located next door will be a great addition to the South Oxford life science cluster.”
A statement from Tozi Ltd said: “In keeping with our approach across our entire portfolio, we have always maintained a productive and open relationship with the tenant Oxford Biomedica, helping to facilitate planning permission for the brand new state of the art R&D campus.”
Mills & Reeve acted as legal advisors for Kadans. Cyril Leonard advised the Tozi and Cripps acted as its legal advisors.
© Thames Tap (powered by ukpropertyforums.com).
Sign up to receive our weekly free journal, The Forum here.